NDC 70771-1826 – Tavaborole
Tavaborole 43.5 mg/mL · Solution · Topical
Product NDC70771-1826
Product details
- Brand name
- Tavaborole
- Generic name
- Tavaborole
- Labeler
- Zydus Lifesciences Limited
- Dosage form
- Solution
- Route
- Topical
- Marketing category
- ANDA · ANDA212294
- Marketed since
- April 24, 2023
- Listing expires
- December 31, 2026
- Pharmacologic class
- Oxaborole Antifungal
Active ingredients
- Tavaborole 43.5 mg/mL
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 70771-1826-0 | 1 BOTTLE, WITH APPLICATOR in 1 CARTON (70771-1826-0) / 10 mL in 1 BOTTLE, WITH APPLICATOR | Apr 24, 2023 |
Other Tavaborole products
- 62332-467 Tavaborole 43.5 mg/mL · Solution · Alembic Pharmaceuticals Inc.
- 46708-467 Tavaborole 43.5 mg/mL · Solution · Alembic Pharmaceuticals Limited
- 62135-663 Tavaborole 43.5 mg/mL · Solution · Chartwell RX, LLC
- 69097-686 Tavaborole 43.5 mg/mL · Solution · Cipla USA Inc.
- 21922-020 Tavaborole 43.5 mg/mL · Solution · Encube Ethicals, Inc.
- 51862-690 Tavaborole 43.5 mg/mL · Solution · Mayne Pharma Commercial LLC
- 72578-102 Tavaborole 43.5 mg/mL · Solution · Viona Pharmaceuticals Inc